Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures

NCT01284556 is registered in ClinicalTrials.gov with West-Ward Pharmaceutical as lead sponsor.

NCT NCT01284556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01284556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Lead sponsor
West-Ward Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2016
Enrollment
314 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy